DB18189InvestigationalProtein Based Therapies
AGuIX is an investigational brand product consisting of a polysiloxane matrix and gadolinium chelates. It is under development as a radiosensitizer to be used during radiation treatment of malignant glioma.
What you can answer from here — as of April 23, 2025
Which companies are running trials of AGuIX, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account